Su Bin Lim
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Chwee Teck Lim (16 shared papers)Darren Wan-Teck Lim (10 shared papers)Swee Jin Tan (3 shared papers)Trifanny Yeo (3 shared papers)Chih Hung Lo (1 shared paper)Shi‐Xun Ma (1 shared paper)Jialiu Zeng (1 shared paper)Leigh Edward Madden (1 shared paper)
- Journals
- Cancers (4 papers)癌症:英文版 (2 papers)Cell Death and Disease (2 papers)Clinical and Molecular Hepatology (2 papers)Nature Communications (2 papers)
- Partner nations
- South KoreaSingaporeUnited States
In The Last Decade
Su Bin Lim
42 papers receiving 1.3k citations
Su Bin Lim's Hit Papers
Peers
Comparison fields: 5 of 96
- Rehabilitation 97
- Cancer Research 169
- Hepatology 89
- Aging 14
- Oncology 168
Countries citing papers authored by Su Bin Lim
This map shows the geographic impact of Su Bin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Bin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Bin Lim more than expected).
Fields of papers citing papers by Su Bin Lim
This network shows the impact of papers produced by Su Bin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Bin Lim. The network helps show where Su Bin Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Su Bin Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 235 | |
| 2 | Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib Hit paper breakdown → | 2023 | 150 |
| 3 | 2017 | 89 | |
| 4 | 2019 | 83 | |
| 5 | 2023 | 64 | |
| 6 | 2019 | 59 | |
| 7 | 2019 | 58 | |
| 8 | 2021 | 49 | |
| 9 | 2019 | 48 | |
| 10 | 2024 | 48 | |
| 11 | 2019 | 37 | |
| 12 | 2016 | 33 | |
| 13 | 2019 | 32 | |
| 14 | 2021 | 26 | |
| 15 | 2021 | 25 | |
| 16 | 2023 | 24 | |
| 17 | 2022 | 21 | |
| 18 | 2022 | 21 | |
| 19 | 2024 | 21 | |
| 20 | 2023 | 19 |
About Su Bin Lim
Su Bin Lim is a scholar working on Oncology, Cancer Research, Hepatology, Physiology and Otorhinolaryngology, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Cells and Metastasis (3 papers), Cellular Mechanics and Interactions (3 papers), Head and Neck Cancer Studies (3 papers), Single-cell and spatial transcriptomics (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Rehabilitation (97 citations), Cancer Research (169 citations), Hepatology (89 citations), Aging (14 citations) and Oncology (168 citations). Su Bin Lim has collaborated with scholars based in South Korea, Singapore and United States. Frequent co-authors include Chwee Teck Lim, Darren Wan-Teck Lim, Swee Jin Tan, Trifanny Yeo, Chih Hung Lo, Shi‐Xun Ma, Jialiu Zeng, Leigh Edward Madden, Jae Youn Cheong and Fazila Binte Abu Bakar Aloweni. Their work appears in journals such as Cancers, 癌症:英文版, Cell Death and Disease, Clinical and Molecular Hepatology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.